KRTL Biotech Expands Antibiotic Product Portfolio
KRTL Holding Group Inc. announced today that its majority-owned subsidiary, KRTL Biotech, is showcasing its expanded range of anti-infective and antibiotic products. This initiative aims to improve access to essential medicines in underserved healthcare markets. The current product line features essential formulations, including broad-spectrum antibiotics and antiparasitics. KRTL Biotech plans to leverage SIGMA Corp.’s GMP-certified…more










